These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Effective local control of prostate cancer by intratumoral injection of (166)Ho-chitosan complex (DW-166HC) in rats. Kwak C; Hong SK; Seong SK; Ryu JM; Park MS; Lee SE Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1400-5. PubMed ID: 16133378 [TBL] [Abstract][Full Text] [Related]
64. Intracavitary radiation therapy for recurrent cystic brain tumors with holmium-166-chico : a pilot study. Ha EJ; Gwak HS; Rhee CH; Youn SM; Choi CW; Cheon GJ J Korean Neurosurg Soc; 2013 Sep; 54(3):175-82. PubMed ID: 24278644 [TBL] [Abstract][Full Text] [Related]
66. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy. Bal CS; Kumar A Trop Gastroenterol; 2008; 29(2):62-70. PubMed ID: 18972764 [TBL] [Abstract][Full Text] [Related]
67. The various therapeutic applications of the medical isotope holmium-166: a narrative review. Klaassen NJM; Arntz MJ; Gil Arranja A; Roosen J; Nijsen JFW EJNMMI Radiopharm Chem; 2019 Aug; 4(1):19. PubMed ID: 31659560 [TBL] [Abstract][Full Text] [Related]
68. A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma. Cho BC; Kim EH; Choi HJ; Kim JH; Roh JK; Chung HC; Ahn JB; Lee JD; Lee JT; Yoo NC; Sohn JH Yonsei Med J; 2005 Dec; 46(6):799-805. PubMed ID: 16385656 [TBL] [Abstract][Full Text] [Related]
69. Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma. Sohn JH; Choi HJ; Lee JT; Lee JD; Kim JH; Moon YM; Park K; Park KB; Kim E; Yoo NC Oncology; 2009; 76(1):1-9. PubMed ID: 19018149 [TBL] [Abstract][Full Text] [Related]
70. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Kim JK; Han KH; Lee JT; Paik YH; Ahn SH; Lee JD; Lee KS; Chon CY; Moon YM Clin Cancer Res; 2006 Jan; 12(2):543-8. PubMed ID: 16428498 [TBL] [Abstract][Full Text] [Related]
71. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma. Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708 [TBL] [Abstract][Full Text] [Related]
72. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial. Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873 [TBL] [Abstract][Full Text] [Related]
74. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC Gastroenterology; 2004 Dec; 127(6):1714-23. PubMed ID: 15578509 [TBL] [Abstract][Full Text] [Related]
75. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. Salem R; Lewandowski R; Roberts C; Goin J; Thurston K; Abouljoud M; Courtney A J Vasc Interv Radiol; 2004 Apr; 15(4):335-45. PubMed ID: 15064336 [TBL] [Abstract][Full Text] [Related]